ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Alfasigma S.p.A. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 59 studies whose lead sponsor is Alfasigma S.p.A. or one of 3 companies grouped under it. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 28, 2026.

Our grouping of 4 registry names, not the registry’s. See them and correct one ↓

Compare Alfasigma with Johnson & Johnson and Sanofi →

Pipeline: 1 program

Each counted once: 1 with a study Alfasigma S.p.A. leads registered in the last two years.

  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Alfasigma S.p.A.’s own registered studies; Alfasigma S.p.A.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Alfasigma S.p.A.’s studies test, most open studies first — 7 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

1 of Alfasigma S.p.A.’s studies under way reach primary completion within a year, all of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. 1J
  9. J
  10. A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 18, 2026.

All 59 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now35%
  • Under way, not recruiting35%
  • Completed2949%
  • Stopped early1932%Terminated 18 · Withdrawn 1
  • Status unknown or other58%

Phase

  • Phase 220
  • Phase 313
  • Phase 17
  • Phase 43

Where

  • United States39
  • Italy24
  • France23
  • Germany22
  • Spain21
  • United Kingdom20

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 713
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 226

By the year each study started; 1 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Alfasigma S.p.A.

  • Alfasigma S.p.A.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    24 studies
  • Intercept Pharmaceuticals
    Acquired — became part of Alfasigma S.p.A., Nov 8, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    22 studies →
  • Pamlab, Inc.
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    10 studies →
  • Pamlab, L.L.C.
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →

Focus areas

Conditions Alfasigma S.p.A. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 59. Browse all 59 →